Zucara Therapeutics zucara.ca


Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing drug therapy to prevent hypoglycemia in people with diabetes. The company's therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in Type 1 diabetes. Preventing hypoglycemia may change diabetes disease management, and consequently, improve both patient health and quality of life.

Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing drug therapy to prevent hypoglycemia in people with diabetes. The company's therapeutic is aimed at inhibiting a hormone in...Show all

Company (Alive / Active)

Phone:

Fax:

1300-661 University Avenue

Toronto, M5G 0B7
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zucara Therapeutics $4.8M Apr 9, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zucara Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)